1/2
04:30 pm
bio
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
Low
Report
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
12/26
04:11 am
bio
Metagenomic Market Research 2025-2029 - Global Market Analysis and Forecasts with Executive and Consultant Guides - A Game Changer in Diagnostics? New Technology Changes Viewpoint on Infections [Yahoo! Finance]
Low
Report
Metagenomic Market Research 2025-2029 - Global Market Analysis and Forecasts with Executive and Consultant Guides - A Game Changer in Diagnostics? New Technology Changes Viewpoint on Infections [Yahoo! Finance]
12/23
10:30 am
bio
Food Safety Testing Market Report (by Contaminants, Pathogens, Types of Food Tested, Technology/Method, Regional Analysis) 2024-2032 [Yahoo! Finance]
Low
Report
Food Safety Testing Market Report (by Contaminants, Pathogens, Types of Food Tested, Technology/Method, Regional Analysis) 2024-2032 [Yahoo! Finance]
12/18
07:42 am
bio
Bioprocess Validation Market to hit USD 1.03 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Medium
Report
Bioprocess Validation Market to hit USD 1.03 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
12/9
09:09 am
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $369.00 to $481.00. They now have an "outperform" rating on the stock.
Medium
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $369.00 to $481.00. They now have an "outperform" rating on the stock.
12/5
11:27 am
bio
Microbiome Diagnostics Market Revenue Projections to 2034 by Product, Technology, Sample, Application, End-user, and by Region [Yahoo! Finance]
Low
Report
Microbiome Diagnostics Market Revenue Projections to 2034 by Product, Technology, Sample, Application, End-user, and by Region [Yahoo! Finance]
11/29
01:00 pm
bio
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Neutral
Report
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
11/28
11:06 am
bio
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies, Trends, Forecasts with Executive Guides [Yahoo! Finance]
Low
Report
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies, Trends, Forecasts with Executive Guides [Yahoo! Finance]
11/24
08:17 pm
bio
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory [Yahoo! Finance]
Low
Report
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory [Yahoo! Finance]
11/22
09:03 am
bio
The Global Market for Mouse Organoid Culture Mediums, 2025-2030: Discover Trends and Regional Growth Projections for Disease Modeling, Drug Screening, Regenerative Medicine, and Toxicology Study Applications [Yahoo! Finance]
Low
Report
The Global Market for Mouse Organoid Culture Mediums, 2025-2030: Discover Trends and Regional Growth Projections for Disease Modeling, Drug Screening, Regenerative Medicine, and Toxicology Study Applications [Yahoo! Finance]
11/21
10:07 am
bio
Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 | Straits Research [Yahoo! Finance]
Low
Report
Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 | Straits Research [Yahoo! Finance]
11/21
09:00 am
bio
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
Low
Report
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
11/14
11:21 am
bio
Digital PCR Market Analysis and Forecast Report 2024-2034 [Yahoo! Finance]
Low
Report
Digital PCR Market Analysis and Forecast Report 2024-2034 [Yahoo! Finance]
11/6
09:45 am
bio
Indonesia Polyacrylamide Industry Report 2024 Market Revenue, Share, Analysis, Value, Companies, Growth, Trends & Forecasts 2020-2030 [Yahoo! Finance]
Low
Report
Indonesia Polyacrylamide Industry Report 2024 Market Revenue, Share, Analysis, Value, Companies, Growth, Trends & Forecasts 2020-2030 [Yahoo! Finance]
11/4
10:47 am
bio
Interpreting Bio-Rad (BIO) International Revenue Trends [Yahoo! Finance]
Low
Report
Interpreting Bio-Rad (BIO) International Revenue Trends [Yahoo! Finance]
11/1
11:06 pm
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/1
07:06 am
bio
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023) [Yahoo! Finance]
Low
Report
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023) [Yahoo! Finance]
10/31
05:35 pm
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Citigroup Inc. from $400.00 to $450.00. They now have a "buy" rating on the stock.
Low
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Citigroup Inc. from $400.00 to $450.00. They now have a "buy" rating on the stock.
10/31
03:47 pm
bio
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $446.00 to $469.00. They now have an "outperform" rating on the stock.
Low
Report
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $446.00 to $469.00. They now have an "outperform" rating on the stock.
10/31
09:00 am
bio
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
Medium
Report
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
10/30
04:15 pm
bio
Bio-Rad Reports Third-Quarter 2024 Financial Results
Medium
Report
Bio-Rad Reports Third-Quarter 2024 Financial Results
10/14
05:30 pm
bio
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
Low
Report
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024